Our thinking

Discover insights, analysis, and thought leadership that are vital for change. Success today requires actionable insights, perspectives that cut through complexity, and tools to navigate the evolving needs of your sector shaping a stronger tomorrow.

Back to Our thinking

English
中文
Deutsch
Español
Français
日本語
Português

News

Court of Appeal hands down reasons for awarding AZ an interim injunction in the UK against Glenmark’s generic dapagliflozin for type II diabetes

24 April 2025

News

When AI and Copyright clash: Chinese courts find AI platform liable for contributory copyright infringement based on AI generated images

11 April 2025

News

UK Court of Appeal grants AstraZeneca an interim injunction against Glenmark’s generic dapagliflozin for type II diabetes

10 April 2025

News

Italy postpones compulsory Nat Cat insurance requirement for SMEs

03 April 2025

News

Publications of Dr. Lukas Rengier

Last Update April 2025

News

State Licensing Spotlight – Prescription Medical Device Manufacturers & Distributors: Enforcement and penalties for operating without a license

17 March 2025

News

IVASS rules for the implementation of the Italian Insurance Arbitrator’s proceedings

10 March 2025

News

Court of Appeal’s decision enables Trucks class action to proceed in the Competition Appeal Tribunal

07 March 2025

News

Italy sets out the legal framework for compulsory Nat Cat insurance

04 March 2025

News

The aftermath of PACCAR – Court of Appeal to hear challenge to the enforceability of widely-used funding agreements

03 March 2025

News

CJEU expands possibilities for cross-border patent infringement injunctions

26 February 2025

Insights and Analysis

New York’s Health Information Privacy Act: what you need to know

26 February 2025

Digital Client Solutions

Empowering you to lead change through our digital solutions.

Learn more

Our thinking

News

News

News

News

News

News

News

News

News

News

News

Insights and Analysis

No results found